Add Sugar to Chitosan: Mucoadhesion and In Vitro Intestinal Permeability of Mannosylated Chitosan Nanocarriers
Open Access
- 11 April 2022
- journal article
- research article
- Published by MDPI AG in Pharmaceutics
- Vol. 14 (4) , 830
Abstract
Crosslinked chitosan nanocarriers (140–160 nm) entrapping coumarin-6 (λex/em = 455/508 nm) with or without surface mannosylation were synthesized and assessed for cytotoxicity, adherence and cellular uptake in Caco-2 cells, flux across Caco-2 monolayers, and mucoadhesion to porcine mucin. Mannosylated and non-mannosylated nanocarriers demonstrated biocompatibility with slow release of coumarin-6 at pH 6.8 and 7.4 over 24 h. Adherence of the non-mannosylated nanocarriers (50 and 150 µg/mL) to Caco-2 cells was ~10% over 24 h, whereas cellular uptake of 25–30% was noted at 4 h. The mannosylated nanocarriers showed a similar adherence to non-mannosylated nanocarriers after 24 h, but a lower cellular uptake (~20%) at 1 h, comparable uptake at 4 h, and a higher uptake (~25–30%) at 24 h. Overall, the nanocarriers did not affect the integrity of Caco-2 monolayers. Mannosylated nanocarriers elicited higher Papp of 1.6 × 10−6 cm/s (50 µg/mL) and 1.2 × 10−6 (150 µg/mL) than the non-mannosylated ones: 9.8 × 10−7 cm/s (50 µg/mL) and 1.0 × 10−6 (150 µg/mL) after 2 h. Non-mannosylated chitosan nanocarriers elicited enhanced adhesion to porcine gut mucin via mucin-filled microchannels due to higher cationic charge density. These results underpin the importance of surface chemistry in the biological interactions of nanocarriers, while highlighting the role of surface hydrophilicity in mucopermeation due to mannosylation.Keywords
Funding Information
- Higher Education Commission Pakistan via the International Research Support Initiative Program (IRSIP) (scholarship (Award No. I-8/HEC/HRD/2019/8762))
- Science Foundation Ireland, the CÚRAM Centre for Medical Devices and the EU Regional Development Fund. (13/RC/2073 P2)
This publication has 49 references indexed in Scilit:
- Design, synthesis and in vitro evaluation of mucoadhesive p-coumarate-thiolated-chitosan as a hydrophobic drug carriersEuropean Journal of Pharmaceutics and Biopharmaceutics, 2014
- Chitosan-Graft-Polyethylenimine/DNA Nanoparticles as Novel Non-Viral Gene Delivery Vectors Targeting OsteoarthritisPLOS ONE, 2014
- Surface charge-specific interactions between polymer nanoparticles and ABC transporters in Caco-2 cellsJournal of Nanoparticle Research, 2013
- Cytotoxicity and cellular uptake of tri-block copolymer nanoparticles with different size and surface characteristicsParticle and Fibre Toxicology, 2012
- Mechanism and consequence of chitosan-mediated reversible epithelial tight junction openingBiomaterials, 2011
- Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissuesAdvanced Drug Delivery Reviews, 2009
- Micro- and macrorheology of mucusAdvanced Drug Delivery Reviews, 2009
- Permeation enhancer effect of chitosan and chitosan derivatives: Comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cellsEuropean Journal of Pharmaceutics and Biopharmaceutics, 2008
- Synthesis and evaluation of the mucoadhesivity of a CD-chitosan derivativeInternational Journal of Pharmaceutics, 2006
- The effect of chitosan and other polycations on tight junction permeability in the human intestinal Caco-2 cell line1 1Abbreviations: AP = apical; BL = basolateral; 2-DOG = 2-deoxyglucose; HBSS = Hanks balanced salt solution; FITC = fluorescein isothiocyanate; HEPES = N-2-hydroxyethyl piperazine-N-4-butanesulfonic acid; HMW = high molecular weight; LMW = low molecular weight; MES = morpholinoethane sulfonic acid; PBS+ = phosphate buffered saline; PEI = polyethylenimine; TEER = trans-epithelial electrical resistance; TRITC = tetramethylrodamine isothiocyanate.The Journal of Nutritional Biochemistry, 2002